Indaptus Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Indaptus Therapeutics, Inc.

Welcome to our dedicated page for Indaptus Therapeutics, Inc. (Nasdaq: INDP) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Indaptus Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Indaptus Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for INDP
TickerTime & DateFilingLink
INDP10:01:31 PM, 8/16/2023
Anderson Glen R. purchased 103352 shares of Indaptus Therapeutics, Inc. (INDP) for ~$216386
Filing
INDP2:06:32 AM, 12/20/2022
Litchev Boyan Vesselinov(Chief Medical Officer) purchased 1150 shares of Indaptus Therapeutics, Inc. (INDP) for ~$2519
Filing
INDP1:00:13 PM, 11/22/2022
Meckler Jeffrey A(CEO and Director) purchased 10000 shares of Indaptus Therapeutics, Inc. (INDP) for ~$18944
Filing